Abstract

Metastasis decreases the survival rate of patients with liver cancer. Therefore, novel anti-metastatic strategies are needed. Korean Red Ginseng (KRG) is often ingested as a functional food with an immune-boosting effect. We investigated a combination of KRG and natural killer (NK) cells as a novel immunotherapy approach. SK-Hep1 cells were injected into the tail vein of NRGA mice to establish an experimental metastasis model. KRG, NK cells, or a combination of KRG and NK cells were administered. Tumor growth was observed using an in vivo imaging system, and metastatic lesions were evaluated by histological analysis and immunohistochemistry. Bioluminescence intensity was lower in the KRG and NK cell combination group than in the other groups, indicating that the combination treatment suppressed the progression of metastasis. CD56 expression was used as a NK cell marker and hematological analysis was performed. The combination treatment also decreased the expression of matrix metalloproteinases and the area of metastatic lesions in liver and bone tissues, as well as increased the eosinophil count. Expression of cytokines-related eosinophils and NK cells was determined by Western blotting analysis. The expression of interleukin 33 (IL33) was induced by the combination of KRG and NK cells. High IL33 expression was associated with prolonged overall survival in the Kaplan–Meier plotter. Our results suggest that KRG enhances the immune activity of NK cells by IL-33 through eosinophils and suppresses metastatic liver cancer progression.

Highlights

  • Received: 13 December 2021Liver cancer is a major cause of death worldwide

  • Cells significantly inhibited metastasis (p < 0.05) compared to control on day 27, and the combination of Korean Red Ginseng (KRG) and natural killer (NK) cells significantly maintained the suppression of metastasis

  • Our results showed that in the group treated with NK cells, the expression of MMP2, MMP7, and MMP9 was similar to that observed in the control group

Read more

Summary

Introduction

Liver cancer is a major cause of death worldwide. Risk factors for liver cancer include chronic hepatitis B or C infection [1]. Primary liver cancer proliferates and progresses through infiltration and invasion. Chemotherapy, targeted therapy, and immunotherapy are used to treat metastatic liver cancer. Immunotherapy activates the immune system, which targets and kills cancer cells [4] via the T cells, B cells, macrophages, and natural killer (NK) cells present in the tumor microenvironment. Immunotherapy is only effective in limited cancer patients. To increase the effectiveness of immunotherapy, activated immune cells are required and the immune system should be modulated. Activated NK cells enhance the anti-cancer effects of T cells and induce cytotoxicity in liver cancer cells [7]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call